Smart Growth: How Future-Proofing Transforms Life Sciences Facilities

After years helping pharmaceutical and biotech organizations deliver complex research and manufacturing environments, I've learned one lesson that keeps repeating itself: the decisions made before design begins determine whether a facility becomes a competitive advantage or an expensive constraint.

A biotech company closes a funding round. They're ready to scale. They call looking for expansion – new capacity, upgraded infrastructure.

Then they hit a wall.

The facility they built five years ago wasn't designed for it. Power systems are maxed out. HVAC capacity can't support new process loads. Utility infrastructure has no room for growth. The retrofit now has to happen in an operating, regulated facility where every change affects commissioning, validation, and production.

Almost every time, it didn't have to happen.

The cost of fixing it later is brutal. Construction inside an active facility. Production disruptions. Delayed trials. Schedule risk. Lost revenue. Costs that dwarf what thoughtful planning would have required in the first place.

The Conversation That Should Happen Before Design Starts

The hard conversation needs to happen before anyone breaks ground.

When life sciences projects struggle, it's rarely because of bad design. It's because nobody asked the difficult questions upfront. Nobody planned for what the science might become in five years—not just what it requires today.

An owner's representative has to push those conversations early. But first, we have to understand the science.

You need to be transparent about what you're trying to accomplish, where your research is headed, what equipment you're planning for, and what success looks like three, five, or even ten years from now. Once we understand that, we can assemble the right team and make sure architects and engineers are designing for operational flexibility—not simply what's easiest to build.

Future-proofing doesn't mean building twice as large.

It means designing adaptable infrastructure. Modular lab planning. Utility capacity that can grow. Mechanical and electrical systems with appropriate redundancy. Space that can accommodate evolving equipment, changing workflows, and future commissioning and validation requirements without forcing major reconstruction.

In life sciences, today’s lab rarely looks the same five years from now. Research evolves. Equipment gets larger, hotter, and more power-intensive. Automation increases. Manufacturing processes mature. I’ve seen facilities designed around today’s requirements struggle when new equipment needed more power, cooling, exhaust, or controls capacity than the building could support. Retrofitting those systems after occupancy is not just expensive. It disrupts research, affects operations, and can delay critical scientific programs. Planning for that evolution on day one is one of the highest-value decisions a project team can make.

Get it right, and you've built confidence into years of operations. Get it wrong, and you're delaying research, disrupting schedules, and potentially pushing back clinical programs.

That's why planning for commissioning, validation, and operational resilience isn't something you add at the end. It starts with the earliest project decisions.

What's Changing

Life sciences facilities are changing quickly. Automation, robotics, and AI are reshaping how labs operate. Facilities aren't becoming more people-dense – they're becoming equipment-dense.

Equipment runs continuously. Data never stops. Critical utilities must support 24/7 operation instead of business hours.

The overall footprint may not grow significantly, infrastructure demand absolutely will.

Power. Cooling. Controls. Network capacity. Backup systems. All of it must support equipment that will likely change several times over the building's life.

That's why flexibility matters more than ever. You're not just designing for today's process. You're designing for technologies that haven't arrived yet.

Before Your Next Project

The most successful projects I've been part of all had one thing in common.

Ownership invested the time upfront.

The leadership team, architects, engineers, and owner's representative understood the science before they started making design decisions. They talked honestly about future programs, operational constraints, cGMP requirements where applicable, validation strategy, and how the facility would need to evolve over time.

The projects that struggle usually skip those conversations.

The decisions you make before design begins determine whether your facility keeps pace with your science and your organization's growth or eventually becomes the thing holding both back.

Get them right the first time.

Life Sciences at Gardiner & Theobald

As investment in pharmaceutical, biotechnology, and life sciences facilities continues to build its life science capabilities, Gardiner & Theobald is expanding its focus on the sector by combining deep technical expertise with the firm's established project management, cost management, program management, and advisory capabilities. From research laboratories to advanced manufacturing environments, G&T helps clients deliver complex, highly regulated facilities while managing risk, maintaining operational continuity, and planning for long-term growth.